AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2021
Jun 7, 2021
34519_dirs_2021-06-07_7b5c315a-4bd4-45a0-80ac-6f3e84690108.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2021-06-03
Reporting Person: ROTHSCHILD JONATHAN E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-03 | Common Stock, par value $0.10 per share | A | 3845 | $7.08 | Acquired | 514003 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-03 | Incentive Stock Options (Right to buy) | $9.52 | D | 11155 | Disposed | 2021-07-17 | Common Stock (11155) | Direct |
Footnotes
F1: These holdings include 226,416 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild
More from IMMUCELL CORP /DE/
Report Publication Announcement
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23